ClearFlow’s mission is to improve patient outcomes and reduce healthcare costs by developing advanced technologies that support best practices and guidelines to prevent chest tube occlusions. ClearFlow’s PleuraFlow® ACT® system is the only device with FDA 510(k)K clearance indicated for the removal of retained blood and the proactive maintenance of chest tube patency after cardiac surgery.
This email address is being protected from spambots. You need JavaScript enabled to view it.
Fax
+49(0)251 67498283
Please send us requests for more literature, information, brochures, test orders or quotes by e‐mail, stating your name, organisation, department, telephone number and e‐mail address.
